Brain Neoplasms

"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Descriptor ID	D001932
MeSH Number(s)	C04.588.614.250.195 C10.228.140.211 C10.551.240.250
Concept/Terms	Brain Neoplasms Brain Neoplasms Neoplasms, Brain Brain Neoplasm Neoplasm, Brain Brain Tumors Brain Tumor Tumor, Brain Tumors, Brain Brain Cancer Brain Cancer Brain Cancers Cancer, Brain Cancers, Brain Malignant Neoplasms, Brain Brain Malignant Neoplasm Brain Malignant Neoplasms Malignant Neoplasm, Brain Cancer of Brain Cancer of the Brain Neoplasms, Brain, Malignant Brain Neoplasms, Malignant Brain Neoplasm, Malignant Malignant Brain Neoplasm Malignant Brain Neoplasms Neoplasms, Intracranial Neoplasms, Intracranial Intracranial Neoplasm Neoplasm, Intracranial Intracranial Neoplasms Brain Tumor, Recurrent Brain Tumor, Recurrent Brain Tumors, Recurrent Recurrent Brain Tumor Recurrent Brain Tumors Malignant Primary Brain Tumors Malignant Primary Brain Tumors Primary Malignant Brain Tumors Malignant Primary Brain Neoplasms Primary Malignant Brain Neoplasms Brain Neoplasms, Malignant, Primary Brain Neoplasms, Primary Malignant Benign Neoplasms, Brain Benign Neoplasms, Brain Benign Neoplasm, Brain Brain Benign Neoplasm Brain Benign Neoplasms Neoplasms, Brain, Benign Brain Neoplasms, Benign Benign Brain Neoplasm Benign Brain Neoplasms Brain Neoplasm, Benign Brain Tumor, Primary Brain Tumor, Primary Brain Tumors, Primary Primary Brain Tumor Primary Brain Tumors Neoplasms, Brain, Primary Brain Neoplasm, Primary Brain Neoplasms, Primary Primary Brain Neoplasm Primary Brain Neoplasms

Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Nervous System Neoplasms [C04.588.614]
Central Nervous System Neoplasms [C04.588.614.250]
Brain Neoplasms [C04.588.614.250.195]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Brain Neoplasms [C10.228.140.211]
Nervous System Neoplasms [C10.551]
Central Nervous System Neoplasms [C10.551.240]
Brain Neoplasms [C10.551.240.250]

Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.

Bar chart showing 237 publications over 25 distinct years, with a maximum of 21 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
1998	3	0	3
1999	2	0	2
2002	2	1	3
2003	6	2	8
2004	12	1	13
2005	13	3	16
2006	14	2	16
2007	16	3	19
2008	19	0	19
2009	21	0	21
2010	17	2	19
2011	9	2	11
2012	9	3	12
2013	8	0	8
2014	7	1	8
2015	5	1	6
2016	11	0	11
2017	7	1	8
2018	1	2	3
2019	6	3	9
2020	4	0	4
2021	6	1	7
2022	4	0	4
2023	6	0	6

Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.

Dalva MB. Brain cancer thrives by hijacking mechanisms to boost synapse strength. Nature. 2023 Nov; 623(7986):260-262.

View in: PubMed
Morikawa A, Li J, Ulintz P, Cheng X, Apfel A, Robinson D, Hopkins A, Kumar-Sinha C, Wu YM, Serhan H, Verbal K, Thomas D, Hayes DF, Chinnaiyan AM, Baladandayuthapani V, Heth J, Soellner MB, Merajver SD, Merrill N. Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment. Cancer Res Commun. 2023 06; 3(6):1093-1103.

View in: PubMed
Cappelli L, Khan MM, Kayne A, Poiset S, Miller R, Ali A, Niazi M, Shi W, Alnahhas I. Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial. Chin Clin Oncol. 2023 Jun; 12(3):23.

View in: PubMed
Pastorino NG, Tomatsu S, Lin A, Doerr J, Waterman Z, Sershen K, Ray P, Rodriguez A, Galileo DS. Using the Chick Embryo Brain as a Model for In Vivo and Ex Vivo Analyses of Human Glioblastoma Cell Behavior. J Vis Exp. 2023 05 26; (195).

View in: PubMed
Miller JJ, Gonzalez Castro LN, McBrayer S, Weller M, Cloughesy T, Portnow J, Andronesi O, Barnholtz-Sloan JS, Baumert BG, Berger MS, Bi WL, Bindra R, Cahill DP, Chang SM, Costello JF, Horbinski C, Huang RY, Jenkins RB, Ligon KL, Mellinghoff IK, Nabors LB, Platten M, Reardon DA, Shi DD, Schiff D, Wick W, Yan H, von Deimling A, van den Bent M, Kaelin WG, Wen PY. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro Oncol. 2023 01 05; 25(1):4-25.

View in: PubMed
Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD, Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA, Chaudhary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J, Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG, Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O, Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L, Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ, Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ, Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch ML. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. JAMA Oncol. 2023 Jan 01; 9(1):112-121.

View in: PubMed
Bose A, Kasle G, Jana R, Maulik M, Thomas D, Mulchandani V, Mukherjee P, Koval M, Das Sarma J. Regulatory role of endoplasmic reticulum resident chaperone protein ERp29 in anti-murine ?-coronavirus host cell response. J Biol Chem. 2023 02; 299(2):102836.

View in: PubMed
Ali AS, Lombardo J, Niazi MZ, Miller RC, Alnahhas I, Martinez NL, Andrews DW, Judy KD, Shi W. Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200?kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study. J Neurooncol. 2022 Nov; 160(2):345-350.

View in: PubMed
Miller R, Niazi M, Russial O, Poiset S, Shi W. Tumor treating fields with radiation for glioblastoma: a narrative review. Chin Clin Oncol. 2022 10; 11(5):40.

View in: PubMed
Blomain E, Berta S, Hug N, Giao D, Meola A, Binkley M, Hui C, Churilla T, Shahsavari N, Desai K, Chang S, Soltys S, Pollom E. Radiotherapy for Brain Metastases from Thyroid Cancer: An Institutional and National Retrospective Cohort Study. Thyroid. 2022 07; 32(7):781-788.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement